Gast ::
| Hauptseite > Publikationsdatenbank > Influence of APOE genotype on alpha 4 beta 2 nicotinic acetylcholine receptor binding in mild Alzheimer‘s dementia as assessed by (-)-[18F] Flubatine PET. > print |
| Hauptseite > Publikationsdatenbank > Influence of APOE genotype on alpha 4 beta 2 nicotinic acetylcholine receptor binding in mild Alzheimer‘s dementia as assessed by (-)-[18F] Flubatine PET. > print |
| 001 | 902741 | ||
| 005 | 20250129092411.0 | ||
| 024 | 7 | _ | |a 10.1007/s00259-019-04486-2 |2 doi |
| 024 | 7 | _ | |a 0340-6997 |2 ISSN |
| 024 | 7 | _ | |a 1432-105X |2 ISSN |
| 024 | 7 | _ | |a 1619-7070 |2 ISSN |
| 024 | 7 | _ | |a 1619-7089 |2 ISSN |
| 024 | 7 | _ | |a altmetric:69269518 |2 altmetric |
| 024 | 7 | _ | |a pmid:31535166 |2 pmid |
| 037 | _ | _ | |a FZJ-2021-04523 |
| 100 | 1 | _ | |a Meyer, P. M. |0 P:(DE-HGF)0 |b 0 |e Corresponding author |
| 111 | 2 | _ | |a Annual Congress of the European Association of Nuclear Medicine |c Barcelona |d 2019-10-12 - 2019-10-16 |w Spain |
| 245 | _ | _ | |a Influence of APOE genotype on alpha 4 beta 2 nicotinic acetylcholine receptor binding in mild Alzheimer‘s dementia as assessed by (-)-[18F] Flubatine PET. |
| 260 | _ | _ | |c 2019 |
| 336 | 7 | _ | |a Abstract |b abstract |m abstract |0 PUB:(DE-HGF)1 |s 1645001184_18216 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a Conference Paper |0 33 |2 EndNote |
| 336 | 7 | _ | |a INPROCEEDINGS |2 BibTeX |
| 336 | 7 | _ | |a conferenceObject |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Conference Abstract |2 DataCite |
| 336 | 7 | _ | |a OTHER |2 ORCID |
| 520 | _ | _ | |a Eur J Nucl Med Mol Imaging 2019; 46 (Suppl 1): EPS-37, S319 |
| 536 | _ | _ | |a 5253 - Neuroimaging (POF4-525) |0 G:(DE-HGF)POF4-5253 |c POF4-525 |f POF IV |x 0 |
| 536 | _ | _ | |a BMBF-01EZ0822 - NorChloro-Fluoro HomoEpiBatidin (NCFHEB) ein potentieller Positronen-Emission Tomographie-(PET) Marker der frühen Alzheimer-Demenz (BMBF-01EZ0822) |0 G:(DE-Juel1)BMBF-01EZ0822 |c BMBF-01EZ0822 |x 1 |
| 588 | _ | _ | |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de |
| 700 | 1 | _ | |a Wilke, S. |0 P:(DE-HGF)0 |b 1 |
| 700 | 1 | _ | |a Hesse, S. |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a Becker, G. A. |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Rullmann, M. |0 P:(DE-HGF)0 |b 4 |
| 700 | 1 | _ | |a Patt, M. |0 P:(DE-HGF)0 |b 5 |
| 700 | 1 | _ | |a J, Luthardt |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Wagenknecht, Gudrun |0 P:(DE-Juel1)133954 |b 7 |u fzj |
| 700 | 1 | _ | |a Hoepping, A. |0 P:(DE-HGF)0 |b 8 |
| 700 | 1 | _ | |a Smits R, R. |0 P:(DE-HGF)0 |b 9 |
| 700 | 1 | _ | |a Sattler, B. |0 P:(DE-HGF)0 |b 10 |
| 700 | 1 | _ | |a Tiepolt, S. |0 P:(DE-HGF)0 |b 11 |
| 700 | 1 | _ | |a W, Deuther-Conrad |0 P:(DE-HGF)0 |b 12 |
| 700 | 1 | _ | |a Barthel, H. |0 P:(DE-HGF)0 |b 13 |
| 700 | 1 | _ | |a Schönknecht, P. |0 P:(DE-HGF)0 |b 14 |
| 700 | 1 | _ | |a Brust, P. |0 P:(DE-HGF)0 |b 15 |
| 700 | 1 | _ | |a Sabri, O. |0 P:(DE-HGF)0 |b 16 |
| 773 | _ | _ | |a 10.1007/s00259-019-04486-2 |y 2019 |g Vol. 46, no. S1, p. 1 - 952 |
| 909 | C | O | |o oai:juser.fz-juelich.de:902741 |p VDB |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 7 |6 P:(DE-Juel1)133954 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Natural, Artificial and Cognitive Information Processing |1 G:(DE-HGF)POF4-520 |0 G:(DE-HGF)POF4-525 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-500 |4 G:(DE-HGF)POF |v Decoding Brain Organization and Dysfunction |9 G:(DE-HGF)POF4-5253 |x 0 |
| 915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2021-02-02 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2021-02-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2021-02-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2021-02-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2021-02-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-02-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2021-02-02 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-02-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2021-02-02 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2021-02-02 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2021-02-02 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EUR J NUCL MED MOL I : 2019 |d 2021-02-02 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b EUR J NUCL MED MOL I : 2019 |d 2021-02-02 |
| 920 | 1 | _ | |0 I:(DE-Juel1)ZEA-2-20090406 |k ZEA-2 |l Zentralinstitut für Elektronik |x 0 |
| 980 | _ | _ | |a abstract |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-Juel1)ZEA-2-20090406 |
| 980 | _ | _ | |a UNRESTRICTED |
| 981 | _ | _ | |a I:(DE-Juel1)PGI-4-20110106 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|